0      0

Future Biotech Portfolio: Challenges in Translating Biotech Innovation into Viable Therapeutics

‐ Jun 26, 2023 10:35am

Over the last few decades, we have seen incredible innovation in different types of therapeutic modalities. Cell and Gene therapies encompass many diverse approaches. Added to that are Live Biological Products (Microbiome) and increasingly complex combination approaches. The challenges facing biopharmaceutical manufacturing groups is how to translate this landscape into processes and supply chains that can support product registration and commercial supply.


You must be logged in and own this session in order to post comments.